in vivo Studies Articles

Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells

OverviewScience Advances has recently published a research article discussing how the PDL1-PD1 immune checkpoint inhibits T cell activation. Checkpoint immunotherapy is known to be a revolutionizing treatment for previously refractive tumors. However, researchers had...

Bio X Cell New Catalog Download

Antibodies for in vivo research since 1997 For over 20 years, scientists have trusted Bio X Cell as their go-to source for in vivo functional grade antibodies. This is reflected in over 15,000 peer-reviewed publications citing Bio X Cell products. We understand this...

InVivoSIM™ Biosimilar Antibodies from Bio X Cell

What Are InVivoSIM™ Antibodies?
Bio X Cell InVivoSIM™ antibodies are research-grade biosimilar monoclonal antibodies. Each biosimilar antibody is produced using recombinant technology and incorporates the same variable region sequence as the original pharmaceutical drug.

A novel in vivo model of COVID-19 Pathogenesis and Treatment

As the COVID-19 pandemic progresses, the need to develop new vaccines and therapeutics intensifies. Animal models of infection play important roles in such discoveries, with mice being the most widely used animal. Unfortunately, commercially available laboratory mice...
InVivoSIM™ Biosimilar Antibodies from Bio X Cell

InVivoSIM™ Biosimilar Antibodies from Bio X Cell

What Are InVivoSIM™ Antibodies?
Bio X Cell InVivoSIM™ antibodies are research-grade biosimilar monoclonal antibodies. Each biosimilar antibody is produced using recombinant technology and incorporates the same variable region sequence as the original pharmaceutical drug.